Literature DB >> 19258250

Global transmission of oseltamivir-resistant influenza.

Anne Moscona1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19258250     DOI： 10.1056/NEJMp0900648

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  200 in total

1.  The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Authors:  Wai Lan Wu; Siu-Ying Lau; Yixin Chen; Genyan Wang; Bobo Wing-Yee Mok; Xi Wen; Pui Wang; Wenjun Song; Tianwei Lin; Kwok-Hung Chan; Kwok-Yung Yuen; Honglin Chen
Journal:  Antiviral Res       Date:  2011-11-25       Impact factor: 5.970

2.  Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Authors:  Peter Reuther; Benjamin Mänz; Linda Brunotte; Martin Schwemmle; Kerstin Wunderlich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Impact of precautionary behaviors during outbreaks of pandemic influenza: modeling of regional differences.

Authors:  Joakim Ekberg; Henrik Eriksson; Magnus Morin; Einar Holm; Magnus Strömgren; Toomas Timpka
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

Review 4.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

5.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

6.  Novel Polyanions Inhibiting Replication of Influenza Viruses.

Authors:  Justyna Ciejka; Aleksandra Milewska; Magdalena Wytrwal; Jacek Wojarski; Anna Golda; Marek Ochman; Maria Nowakowska; Krzysztof Szczubialka; Krzysztof Pyrc
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins.

Authors:  Toru Yamaguchi-Sasaki; Seiken Tokura; Yuya Ogata; Takanori Kawaguchi; Yutaka Sugaya; Ryo Takahashi; Kanako Iwakiri; Tomoko Abe-Kumasaka; Ippei Yoshida; Kaho Arikawa; Hiroyuki Sugiyama; Kosuke Kanuma
Journal:  ACS Med Chem Lett       Date:  2020-04-10       Impact factor: 4.345

8.  Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.

Authors:  Rachel R Higgins; Melissa Beniprashad; Eddie Chong-King; Yan Li; Nathalie Bastien; Donald E Low; Jonathan B Gubbay
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

9.  Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

Authors:  Gallen B Triana-Baltzer; Rebecca L Sanders; Maria Hedlund; Kellie A Jensen; Laura M Aschenbrenner; Jeffrey L Larson; Fang Fang
Journal:  J Antimicrob Chemother       Date:  2010-11-21       Impact factor: 5.790

10.  In Vitro and In Vivo Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated In Vitro Selection.

Authors:  Khristine Kaith S Lloren; Jin Jung Kwon; Won-Suk Choi; Ju Hwan Jeong; Su Jeong Ahn; Young Ki Choi; Yun Hee Baek; Min-Suk Song
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.